Studies on the characterization of plasmodium vivax strains from Central America.
D000818:Animals; D002489:Central America; D002738:Chloroquine / Q000627:therapeutic use; D000882:Haplorhini; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use; D008288:Malaria / Q000188:drug therapy / Q000209:etiology*; D010966:Plasmodium vivax / Q000302:isolation & purification; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D012008:Recurrence; D013997:Time Factors
D002738:Chloroquine; D011803:Quinine; D008034:Lincomycin; D011319:Primaquine; D002727:Proguanil; D011739:Pyrimethamine